278 related articles for article (PubMed ID: 36306790)
1. The m
Weng H; Huang F; Yu Z; Chen Z; Prince E; Kang Y; Zhou K; Li W; Hu J; Fu C; Aziz T; Li H; Li J; Yang Y; Han L; Zhang S; Ma Y; Sun M; Wu H; Zhang Z; Wunderlich M; Robinson S; Braas D; Hoeve JT; Zhang B; Marcucci G; Mulloy JC; Zhou K; Tao HF; Deng X; Horne D; Wei M; Huang H; Chen J
Cancer Cell; 2022 Dec; 40(12):1566-1582.e10. PubMed ID: 36306790
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.
Willems L; Jacque N; Jacquel A; Neveux N; Maciel TT; Lambert M; Schmitt A; Poulain L; Green AS; Uzunov M; Kosmider O; Radford-Weiss I; Moura IC; Auberger P; Ifrah N; Bardet V; Chapuis N; Lacombe C; Mayeux P; Tamburini J; Bouscary D
Blood; 2013 Nov; 122(20):3521-32. PubMed ID: 24014241
[TBL] [Abstract][Full Text] [Related]
3. m
Zhao Y; Zhou Y; Qian Y; Wei W; Lin X; Mao S; Sun J; Jin J
Clin Transl Med; 2024 Apr; 14(4):e1628. PubMed ID: 38572589
[TBL] [Abstract][Full Text] [Related]
4. Decoding m
Cheng Y; Gao Z; Zhang T; Wang Y; Xie X; Han G; Li Y; Yin R; Chen Y; Wang P; Hu J; Zhang T; Guo C; Chai J; Wang J; Cui M; Gao K; Liu W; Yao S; Lu P; Cao Z; Zheng Y; Chang J; Liu Z; Song Q; Li W; Zhou F; Zhang H
Cell Stem Cell; 2023 Jan; 30(1):69-85.e7. PubMed ID: 36574771
[TBL] [Abstract][Full Text] [Related]
5. The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation.
Amaya ML; Inguva A; Pei S; Jones C; Krug A; Ye H; Minhajuddin M; Winters A; Furtek SL; Gamboni F; Stevens B; D'Alessandro A; Pollyea DA; Reigan P; Jordan CT
Blood; 2022 Jan; 139(4):584-596. PubMed ID: 34525179
[TBL] [Abstract][Full Text] [Related]
6. IGF2BP2 promotes lncRNA DANCR stability mediated glycolysis and affects the progression of FLT3-ITD + acute myeloid leukemia.
Wu S; Chi C; Weng S; Zhou W; Liu Z
Apoptosis; 2023 Aug; 28(7-8):1035-1047. PubMed ID: 37060505
[TBL] [Abstract][Full Text] [Related]
7. IGF2BP2 Overexpression Indicates Poor Survival in Patients with Acute Myelocytic Leukemia.
He X; Li W; Liang X; Zhu X; Zhang L; Huang Y; Yu T; Li S; Chen Z
Cell Physiol Biochem; 2018; 51(4):1945-1956. PubMed ID: 30513526
[TBL] [Abstract][Full Text] [Related]
8. LncRNA
Jiang J; Dong W; Zhang W; Wang Q; Wang R; Wang J; Wu H; Dong H; Zhao RC; Wang J; Li Z
Discov Med; 2023 Dec; 35(179):995-1014. PubMed ID: 38058065
[TBL] [Abstract][Full Text] [Related]
9. LINC00987 knockdown inhibits the progression of acute myeloid leukemia by suppressing IGF2BP2-mediated PA2G4 expression.
Liu C; Ma Y; Wang R; Su G
Anticancer Drugs; 2022 Jan; 33(1):e207-e217. PubMed ID: 34407052
[TBL] [Abstract][Full Text] [Related]
10. RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia.
Shen C; Sheng Y; Zhu AC; Robinson S; Jiang X; Dong L; Chen H; Su R; Yin Z; Li W; Deng X; Chen Y; Hu YC; Weng H; Huang H; Prince E; Cogle CR; Sun M; Zhang B; Chen CW; Marcucci G; He C; Qian Z; Chen J
Cell Stem Cell; 2020 Jul; 27(1):64-80.e9. PubMed ID: 32402250
[TBL] [Abstract][Full Text] [Related]
11. The m
Zhou Y; Yan J; Huang H; Liu L; Ren L; Hu J; Jiang X; Zheng Y; Xu L; Zhong F; Li X
Cell Death Dis; 2024 Mar; 15(3):189. PubMed ID: 38443347
[TBL] [Abstract][Full Text] [Related]
12. N
Zhang Z; Xing Y; Gao W; Yang L; Shi J; Song W; Li T
Bioengineered; 2022 May; 13(5):11541-11550. PubMed ID: 35502827
[TBL] [Abstract][Full Text] [Related]
13. Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia.
Xiao Y; Hu B; Guo Y; Zhang D; Zhao Y; Chen Y; Li N; Yu L
Curr Treat Options Oncol; 2023 Aug; 24(8):1021-1035. PubMed ID: 37249801
[TBL] [Abstract][Full Text] [Related]
14. RNA-binding proteins as drivers of AML and novel therapeutic targets.
Qin T; Cheng Y; Wang X
Leuk Lymphoma; 2022 May; 63(5):1045-1057. PubMed ID: 35075986
[TBL] [Abstract][Full Text] [Related]
15. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
16. Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer.
Hassanein M; Qian J; Hoeksema MD; Wang J; Jacobovitz M; Ji X; Harris FT; Harris BK; Boyd KL; Chen H; Eisenberg R; Massion PP
Int J Cancer; 2015 Oct; 137(7):1587-97. PubMed ID: 25821004
[TBL] [Abstract][Full Text] [Related]
17. Glutamine addiction activates polyglutamine-based nanocarriers delivering therapeutic siRNAs to orthotopic lung tumor mediated by glutamine transporter SLC1A5.
Wang C; Wu J; Wang Z; Yang Z; Li Z; Deng H; Li L; Peng X; Feng M
Biomaterials; 2018 Nov; 183():77-92. PubMed ID: 30149232
[TBL] [Abstract][Full Text] [Related]
18. FBW7/GSK3β mediated degradation of IGF2BP2 inhibits IGF2BP2-SLC7A5 positive feedback loop and radioresistance in lung cancer.
Zhou Z; Zhang B; Deng Y; Deng S; Li J; Wei W; Wang Y; Wang J; Feng Z; Che M; Yang X; Meng J; Li Y; Hu Y; Sun Y; Wen L; Huang F; Sheng Y; Wan C; Yang K
J Exp Clin Cancer Res; 2024 Jan; 43(1):34. PubMed ID: 38281999
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the m
Feng P; Chen D; Wang X; Li Y; Li Z; Li B; Zhang Y; Li W; Zhang J; Ye J; Zhao B; Li J; Ji C
Leukemia; 2022 Sep; 36(9):2180-2188. PubMed ID: 35915142
[TBL] [Abstract][Full Text] [Related]
20. Critical role of ASCT2-mediated amino acid metabolism in promoting leukaemia development and progression.
Ni F; Yu WM; Li Z; Graham DK; Jin L; Kang S; Rossi MR; Li S; Broxmeyer HE; Qu CK
Nat Metab; 2019 Mar; 1(3):390-403. PubMed ID: 31535081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
